We narrowed to 55,758 results for: ran

1. pAAV-synapsin-HaloCaMP1a-EGFP (AAV9)

   Viral Prep

   #138327-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-synapsin-HaloCaMP1a-EGFP (#138327). In addition to the viral particles, you will also receive purified pAAV-synapsin-HaloCaMP1a-EGFP plasmid DNA. Synapsin-driven HaloCaMP1a, a far-red calcium sensor, fused to EGFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Eric Schreiter

   Article

   Deo et al Nat Chem Biol. 2021 Jun;17(6):718-723. d

   Promoter

   Syn

   Tags

   EGFP

   Available Since

   Sept. 15, 2021

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-synapsin-HaloCaMP1b-EGFP (AAV9)

   Viral Prep

   #138328-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-synapsin-HaloCaMP1b-EGFP (#138328). In addition to the viral particles, you will also receive purified pAAV-synapsin-HaloCaMP1b-EGFP plasmid DNA. Synapsin-driven HaloCaMP1b, a far-red calcium sensor, fused to EGFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Eric Schreiter

   Article

   Deo et al Nat Chem Biol. 2021 Jun;17(6):718-723. d

   Promoter

   Syn

   Tags

   EGFP

   Available Since

   Sept. 15, 2021

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-CaMKIIa-Flpo (AAV8)

   Viral Prep

   #183535-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-Flpo (#183535). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-Flpo plasmid DNA. CamKIIa-driven expression of Flpo recombinase. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Fan et al Cell. 2023 Feb 2;186(3):543-559.e19. doi

   Promoter

   CaMKII

   Available Since

   Oct. 8, 2025

   Availability

   Academic Institutions and Nonprofits only

4. CRASP-Seq CBC Backbone

   Pooled Library

   #232068

   Purpose

   The CRASP-Seq backbone is designed to accommodate the cloning of diverse gRNA libraries. It includes a cell barcode (CBC), which enhances its functionality by enabling library preparation.

   Depositor

   Thomas Gonatopoulos-Pournatzis

   Article

   Behera et al bioRxiv [Preprint]. 2025 Apr 26:2025.04.

   Expression

   Mammalian

   Species

   Homo sapiens

   Use

   CRISPR and Lentiviral

   Available Since

   Oct. 28, 2025

   Availability

   Academic Institutions and Nonprofits only

5. CRASP-Seq BE Tiling v1 empty

   Pooled Library

   #232070

   Purpose

   Tiling guides designed to target 39 splicing-related genes, along with several thousand control gRNAs. Optimized for CRASP-Seq experiments combined with high-throughput base editing mutagenesis.

   Depositor

   Thomas Gonatopoulos-Pournatzis

   Article

   Behera et al bioRxiv [Preprint]. 2025 Apr 26:2025.04.

   Expression

   Mammalian

   Species

   Homo sapiens

   Use

   CRISPR and Lentiviral

   Available Since

   Oct. 28, 2025

   Availability

   Academic Institutions and Nonprofits only

6. B. subtilis CRISPRi Essential Gene Knockdown Library

   Plasmid Kit

   #1000000116

   Purpose

   B. subtilis CRISPRi Essential Gene Knockdown Library: Arrayed library that uses CRISPRi to sterically hinder transcription and therefore knock down expression of essential genes.

   Depositor

   Carol Gross

   Available Since

   Sept. 1, 2017

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-TRE-DIO-eYFP (AAV1)

   Viral Prep

   #117383-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-TRE-DIO-eYFP (#117383). In addition to the viral particles, you will also receive purified pAAV-TRE-DIO-eYFP plasmid DNA. Tet-inducible, Cre-dependent eYFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   TRE

   Tags

   eYFP (Tet-inducible, Cre-dependent)

   Available Since

   Jan. 6, 2022

   Availability

   Academic Institutions and Nonprofits only

8. AAV-CAG-hChR2-H134R-tdTomato (AAV Retrograde)

   Viral Prep

   #28017-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from AAV-CAG-hChR2-H134R-tdTomato (#28017). In addition to the viral particles, you will also receive purified AAV-CAG-hChR2-H134R-tdTomato plasmid DNA. Humanized channelrhodopsin H134R mutant fused to tdTomato, under the control of the CAG promoter. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karel Svoboda

   Article

   Mao et al Neuron. 2011 Oct 6;72(1):111-23.

   Promoter

   CAG

   Tags

   tdTomato

   Available Since

   June 20, 2017

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-hSyn1-eYFP (AAV Retrograde)

   Viral Prep

   #117382-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   Syn

   Tags

   eYFP

   Available Since

   Oct. 18, 2021

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-CAG-eYFP (AAV Retrograde)

    Viral Prep

    #104055-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

    Promoter

    CAG

    Tags

    EYFP

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-flex-taCasp3-TEVp (AAV5)

    Viral Prep

    #45580-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-flex-taCasp3-TEVp (#45580). In addition to the viral particles, you will also receive purified pAAV-flex-taCasp3-TEVp plasmid DNA. EF1a-driven, Cre-dependent, bicicstronic expression of designer pro-taCasp3 and TEVp. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jim Wells, Nirao Shah

    Article

    Yang et al Cell. 2013 May 9;153(4):896-909. doi: 10

    Promoter

    EF1a

    Available Since

    Sept. 25, 2020

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-CAG-DIO-ChroME-ST-P2A-H2B-mRuby3 (AAV9)

    Viral Prep

    #108912-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CAG-DIO-ChroME-ST-P2A-H2B-mRuby3 (#108912). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-ChroME-ST-P2A-H2B-mRuby3 plasmid DNA. CAG-driven, Cre-dependent ChroME-ST-P2A-H2B-mRuby3 expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Hillel Adesnik

    Article

    Mardinly et al Nat Neurosci. 2018 Apr 30. pii: 10.1038/

    Promoter

    CAG

    Tags

    mRuby3 (Cre-dependent)

    Available Since

    Nov. 20, 2018

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-synP-FLEX-splitTVA-EGFP-B19G (AAV1)

    Viral Prep

    #52473-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-synP-FLEX-splitTVA-EGFP-B19G (#52473). In addition to the viral particles, you will also receive purified pAAV-synP-FLEX-splitTVA-EGFP-B19G plasmid DNA. Helper virus for monosynaptic tracing with rabies virus. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ian Wickersham

    Article

    Kohara et al Nat Neurosci. 2014 Feb;17(2):269-79. doi

    Promoter

    Syn

    Tags

    EGFP (Cre-dependent)

    Available Since

    Dec. 18, 2018

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-flex-taCasp3-TEVp (AAV1)

    Viral Prep

    #45580-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-flex-taCasp3-TEVp (#45580). In addition to the viral particles, you will also receive purified pAAV-flex-taCasp3-TEVp plasmid DNA. EF1a-driven, Cre-dependent, bicicstronic expression of designer pro-taCasp3 and TEVp. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jim Wells, Nirao Shah

    Article

    Yang et al Cell. 2013 May 9;153(4):896-909. doi: 10

    Promoter

    EF1a

    Available Since

    Dec. 3, 2020

    Availability

    Academic Institutions and Nonprofits only

15. biGBac Kit

    Plasmid Kit

    #1000000088

    Purpose

    Generation of baculoviral transfer vectors coding up to 25 protein complex subunits in two Gibson assembly steps. Multisubunit protein complexes can be generated in baculovirus-infected insect cells.

    Depositor

    Jan-Michael Peters

    Available Since

    Oct. 25, 2016

    Availability

    Academic Institutions and Nonprofits only

16. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV1)

    Viral Prep

    #87306-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Li Zhang

    Article

    Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

    Promoter

    EF1a

    Available Since

    April 18, 2019

    Availability

    Academic Institutions and Nonprofits only

17. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV9)

    Viral Prep

    #87306-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Li Zhang

    Article

    Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

    Promoter

    EF1a

    Available Since

    Jan. 26, 2021

    Availability

    Academic Institutions and Nonprofits only

18. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV8)

    Viral Prep

    #87306-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Li Zhang

    Article

    Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

    Promoter

    EF1a

    Available Since

    Jan. 26, 2021

    Availability

    Academic Institutions and Nonprofits only

19. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV2)

    Viral Prep

    #87306-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Li Zhang

    Article

    Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

    Promoter

    EF1a

    Available Since

    Aug. 24, 2020

    Availability

    Academic Institutions and Nonprofits only

20. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV5)

    Viral Prep

    #87306-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Li Zhang

    Article

    Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

    Promoter

    EF1a

    Available Since

    July 22, 2020

    Availability

    Academic Institutions and Nonprofits only